+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Blood Glucose Monitoring Market - Global Forecast 2026-2032- Product Image
Blood Glucose Monitoring Market - Global Forecast 2026-2032- Product Image
New

Blood Glucose Monitoring Market - Global Forecast 2026-2032

  • PDF Icon

    Report

  • 195 Pages
  • January 2026
  • Region: Global
  • 360iResearch™
  • ID: 5666055
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The blood glucose monitoring market is experiencing a significant inflection, propelled by innovation, regulatory evolution, and evolving patient and provider expectations. Improved technologies, digital health integration, and new commercial models are reshaping care pathways and business priorities alike.

Market Snapshot: Blood Glucose Monitoring Market

The Blood Glucose Monitoring Market grew from USD 15.27 billion in 2025 to USD 16.56 billion in 2026. It is expected to continue at a CAGR of 8.61% to reach USD 27.23 billion by 2032. This expansion is driven by rapid adoption of continuous and real-time monitoring, increased demand for remote care solutions, and a shift toward patient-centered diabetes management.

Scope & Segmentation

This report delivers a holistic analysis of the blood glucose monitoring ecosystem, emphasizing transformative trends and strategic frameworks. Comprehensive segmentation covers:

  • Application Categories: Devices serving gestational, type 1, and type 2 diabetes each face unique adoption drivers and feature requirements.
  • End-User Settings: Ambulatory clinics, diagnostic labs, home care, and hospitals each demand tailored product design, ranging from connectivity to clinical-grade reliability.
  • Product Types: Continuous glucose monitoring (CGM) systems—both intermittently scanned and real-time—as well as self-monitoring solutions including glucose meters, lancing devices, and test strips.
  • Distribution Channels: Institutional procurement through hospitals and clinics, direct channels via online retailers and subscriptions, and pharmacy-based over-the-counter routes.
  • Regions: The Americas, Europe, Middle East & Africa, and Asia-Pacific, each with distinct regulatory and reimbursement landscapes.
  • Technological Solutions: Sensor miniaturization, smartphone integration, AI-driven analytics, and telehealth platform compatibility.

Key Takeaways

  • Technological advances, such as smaller sensors and AI analytics, are driving higher patient uptake by simplifying use and enabling tailored interventions.
  • Integrated care and digital therapeutics are promoting a shift from episodic checks to continuous monitoring and data-informed treatment adjustments.
  • Regulatory clarity, payer recognition, and evolving reimbursement policies accelerate product adoption and influence commercial and channel strategies.
  • Regional markets require localized expertise—strategies in the Americas differ from those in Europe, Middle East & Africa, or Asia-Pacific, reflecting varied infrastructure and consumer attitudes.
  • Supply chain resilience is increasingly prioritized, with manufacturers diversifying sourcing and adopting modular design to manage tariff impacts and operational risks.

Tariff Impact on Supply Chains and Manufacturer Strategy

U.S. tariff adjustments in 2025 have altered supply chain calculations for glucose monitoring devices. Manufacturers are responding by:

  • Reevaluating supplier relationships and sourcing strategies to manage increased costs and safeguard inventory continuity.
  • Negotiating longer-term agreements and building inventory buffers to reduce single-source dependencies.
  • Moving toward regional manufacturing and modular product designs to better absorb external shocks and regulatory requirements.
  • Exploring vertical integration for critical components and fostering closer partnerships with tier-one suppliers.

Methodology & Data Sources

This research uses primary interviews with clinical leaders, procurement teams, and technology executives, complemented by curated secondary analysis of regulatory changes and clinical literature. Qualitative and quantitative methods, triangulation, and sensitivity checks ensure results are robust and actionable.

Why This Report Matters

  • Enables senior decision-makers to align product, supply chain, and commercial strategies with evolving care and reimbursement trends.
  • Supports effective market entry and positioning through regional, segment-level, and technology insights.
  • Supplies an evidence-backed foundation for investment planning, partnership development, and go-to-market execution.

Conclusion

The blood glucose monitoring sector is advancing through integrated technologies and evolving care models. Organizations that combine operational agility with clinical credibility and payer alignment will be best positioned to shape future market success.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. Market Share Analysis, 2025
3.5. FPNV Positioning Matrix, 2025
3.6. New Revenue Opportunities
3.7. Next-Generation Business Models
3.8. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Porter’s Five Forces Analysis
4.4. PESTLE Analysis
4.5. Market Outlook
4.5.1. Near-Term Market Outlook (0-2 Years)
4.5.2. Medium-Term Market Outlook (3-5 Years)
4.5.3. Long-Term Market Outlook (5-10 Years)
4.6. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of United States Tariffs 2025
7. Cumulative Impact of Artificial Intelligence 2025
8. Blood Glucose Monitoring Market, by Product Type
8.1. Continuous Glucose Monitoring Systems
8.1.1. Intermittently Scanned Systems
8.1.2. Real Time Continuous Systems
8.2. Self Monitoring Devices
8.2.1. Control Solutions
8.2.2. Glucose Meters
8.2.3. Lancing Devices
8.2.4. Test Strips
9. Blood Glucose Monitoring Market, by Application
9.1. Gestational Diabetes
9.2. Type 1 Diabetes
9.3. Type 2 Diabetes
10. Blood Glucose Monitoring Market, by End User
10.1. Ambulatory Care
10.2. Diagnostic Laboratories
10.3. Home Care
10.4. Hospitals
11. Blood Glucose Monitoring Market, by Distribution Channel
11.1. Hospitals Clinics
11.2. Online Retailers
11.3. Pharmacies
12. Blood Glucose Monitoring Market, by Region
12.1. Americas
12.1.1. North America
12.1.2. Latin America
12.2. Europe, Middle East & Africa
12.2.1. Europe
12.2.2. Middle East
12.2.3. Africa
12.3. Asia-Pacific
13. Blood Glucose Monitoring Market, by Group
13.1. ASEAN
13.2. GCC
13.3. European Union
13.4. BRICS
13.5. G7
13.6. NATO
14. Blood Glucose Monitoring Market, by Country
14.1. United States
14.2. Canada
14.3. Mexico
14.4. Brazil
14.5. United Kingdom
14.6. Germany
14.7. France
14.8. Russia
14.9. Italy
14.10. Spain
14.11. China
14.12. India
14.13. Japan
14.14. Australia
14.15. South Korea
15. United States Blood Glucose Monitoring Market
16. China Blood Glucose Monitoring Market
17. Competitive Landscape
17.1. Market Concentration Analysis, 2025
17.1.1. Concentration Ratio (CR)
17.1.2. Herfindahl Hirschman Index (HHI)
17.2. Recent Developments & Impact Analysis, 2025
17.3. Product Portfolio Analysis, 2025
17.4. Benchmarking Analysis, 2025
17.5. Abbott Laboratories
17.6. AdvaCare Pharma
17.7. Advin Health Care
17.8. ARKRAY, Inc.
17.9. Ascensia Diabetes Care Holdings AG by PHC Holdings Corporation
17.10. B. Braun Melsungen AG
17.11. BAYER AG
17.12. Becton, Dickinson and Company
17.13. Dexcom, Inc.
17.14. F. Hoffmann-La Roche Ltd.
17.15. GlySens Incorporated
17.16. I-SENS, Inc.
17.17. Insulet Corporation
17.18. Johnson & Johnson Services, Inc.
17.19. LifeScan IP Holding, LLC.
17.20. Medtronic PLC
17.21. Medtrum Technologies Inc.
17.22. Nemaura Medical Inc.
17.23. Nipro Europe Group Companies
17.24. Nova Biomedical
17.25. Novo Nordisk A/s
17.26. NXP Semiconductors N.V.
17.27. PHC Holding Corporation
17.28. Prodigy Diabetes Care LLC
17.29. Sanofi S.A.
17.30. Senseonics Holdings Inc.
17.31. Sinocare Inc.
17.32. Teladoc Health, Inc.
17.33. Terumo Corporation
17.34. Ypsomed AG
List of Figures
FIGURE 1. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 2. GLOBAL BLOOD GLUCOSE MONITORING MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 3. GLOBAL BLOOD GLUCOSE MONITORING MARKET, FPNV POSITIONING MATRIX, 2025
FIGURE 4. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 5. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 6. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 7. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 9. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 11. UNITED STATES BLOOD GLUCOSE MONITORING MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 12. CHINA BLOOD GLUCOSE MONITORING MARKET SIZE, 2018-2032 (USD MILLION)
List of Tables
TABLE 1. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 2. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 3. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
TABLE 4. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 5. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 6. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING SYSTEMS, 2018-2032 (USD MILLION)
TABLE 7. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY INTERMITTENTLY SCANNED SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
TABLE 8. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY INTERMITTENTLY SCANNED SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 9. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY INTERMITTENTLY SCANNED SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 10. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY REAL TIME CONTINUOUS SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
TABLE 11. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY REAL TIME CONTINUOUS SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 12. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY REAL TIME CONTINUOUS SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 13. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY SELF MONITORING DEVICES, BY REGION, 2018-2032 (USD MILLION)
TABLE 14. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY SELF MONITORING DEVICES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 15. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY SELF MONITORING DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 16. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY SELF MONITORING DEVICES, 2018-2032 (USD MILLION)
TABLE 17. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY CONTROL SOLUTIONS, BY REGION, 2018-2032 (USD MILLION)
TABLE 18. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY CONTROL SOLUTIONS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 19. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY CONTROL SOLUTIONS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 20. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY GLUCOSE METERS, BY REGION, 2018-2032 (USD MILLION)
TABLE 21. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY GLUCOSE METERS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 22. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY GLUCOSE METERS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 23. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY LANCING DEVICES, BY REGION, 2018-2032 (USD MILLION)
TABLE 24. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY LANCING DEVICES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 25. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY LANCING DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 26. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY TEST STRIPS, BY REGION, 2018-2032 (USD MILLION)
TABLE 27. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY TEST STRIPS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 28. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY TEST STRIPS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 29. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 30. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY GESTATIONAL DIABETES, BY REGION, 2018-2032 (USD MILLION)
TABLE 31. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY GESTATIONAL DIABETES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 32. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY GESTATIONAL DIABETES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 33. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY TYPE 1 DIABETES, BY REGION, 2018-2032 (USD MILLION)
TABLE 34. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY TYPE 1 DIABETES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 35. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY TYPE 1 DIABETES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 36. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY TYPE 2 DIABETES, BY REGION, 2018-2032 (USD MILLION)
TABLE 37. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY TYPE 2 DIABETES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 38. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY TYPE 2 DIABETES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 39. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 40. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY AMBULATORY CARE, BY REGION, 2018-2032 (USD MILLION)
TABLE 41. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY AMBULATORY CARE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 42. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY AMBULATORY CARE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 43. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 44. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 45. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 46. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY HOME CARE, BY REGION, 2018-2032 (USD MILLION)
TABLE 47. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY HOME CARE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 48. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY HOME CARE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 49. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
TABLE 50. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 51. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 52. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 53. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY HOSPITALS CLINICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 54. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY HOSPITALS CLINICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 55. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY HOSPITALS CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 56. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY ONLINE RETAILERS, BY REGION, 2018-2032 (USD MILLION)
TABLE 57. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY ONLINE RETAILERS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 58. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY ONLINE RETAILERS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 59. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY PHARMACIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 60. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY PHARMACIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 61. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY PHARMACIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 62. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 63. AMERICAS BLOOD GLUCOSE MONITORING MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 64. AMERICAS BLOOD GLUCOSE MONITORING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 65. AMERICAS BLOOD GLUCOSE MONITORING MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING SYSTEMS, 2018-2032 (USD MILLION)
TABLE 66. AMERICAS BLOOD GLUCOSE MONITORING MARKET SIZE, BY SELF MONITORING DEVICES, 2018-2032 (USD MILLION)
TABLE 67. AMERICAS BLOOD GLUCOSE MONITORING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 68. AMERICAS BLOOD GLUCOSE MONITORING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 69. AMERICAS BLOOD GLUCOSE MONITORING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 70. NORTH AMERICA BLOOD GLUCOSE MONITORING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 71. NORTH AMERICA BLOOD GLUCOSE MONITORING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 72. NORTH AMERICA BLOOD GLUCOSE MONITORING MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING SYSTEMS, 2018-2032 (USD MILLION)
TABLE 73. NORTH AMERICA BLOOD GLUCOSE MONITORING MARKET SIZE, BY SELF MONITORING DEVICES, 2018-2032 (USD MILLION)
TABLE 74. NORTH AMERICA BLOOD GLUCOSE MONITORING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 75. NORTH AMERICA BLOOD GLUCOSE MONITORING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 76. NORTH AMERICA BLOOD GLUCOSE MONITORING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 77. LATIN AMERICA BLOOD GLUCOSE MONITORING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 78. LATIN AMERICA BLOOD GLUCOSE MONITORING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 79. LATIN AMERICA BLOOD GLUCOSE MONITORING MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING SYSTEMS, 2018-2032 (USD MILLION)
TABLE 80. LATIN AMERICA BLOOD GLUCOSE MONITORING MARKET SIZE, BY SELF MONITORING DEVICES, 2018-2032 (USD MILLION)
TABLE 81. LATIN AMERICA BLOOD GLUCOSE MONITORING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 82. LATIN AMERICA BLOOD GLUCOSE MONITORING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 83. LATIN AMERICA BLOOD GLUCOSE MONITORING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 84. EUROPE, MIDDLE EAST & AFRICA BLOOD GLUCOSE MONITORING MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 85. EUROPE, MIDDLE EAST & AFRICA BLOOD GLUCOSE MONITORING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 86. EUROPE, MIDDLE EAST & AFRICA BLOOD GLUCOSE MONITORING MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING SYSTEMS, 2018-2032 (USD MILLION)
TABLE 87. EUROPE, MIDDLE EAST & AFRICA BLOOD GLUCOSE MONITORING MARKET SIZE, BY SELF MONITORING DEVICES, 2018-2032 (USD MILLION)
TABLE 88. EUROPE, MIDDLE EAST & AFRICA BLOOD GLUCOSE MONITORING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 89. EUROPE, MIDDLE EAST & AFRICA BLOOD GLUCOSE MONITORING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 90. EUROPE, MIDDLE EAST & AFRICA BLOOD GLUCOSE MONITORING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 91. EUROPE BLOOD GLUCOSE MONITORING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 92. EUROPE BLOOD GLUCOSE MONITORING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 93. EUROPE BLOOD GLUCOSE MONITORING MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING SYSTEMS, 2018-2032 (USD MILLION)
TABLE 94. EUROPE BLOOD GLUCOSE MONITORING MARKET SIZE, BY SELF MONITORING DEVICES, 2018-2032 (USD MILLION)
TABLE 95. EUROPE BLOOD GLUCOSE MONITORING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 96. EUROPE BLOOD GLUCOSE MONITORING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 97. EUROPE BLOOD GLUCOSE MONITORING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 98. MIDDLE EAST BLOOD GLUCOSE MONITORING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 99. MIDDLE EAST BLOOD GLUCOSE MONITORING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 100. MIDDLE EAST BLOOD GLUCOSE MONITORING MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING SYSTEMS, 2018-2032 (USD MILLION)
TABLE 101. MIDDLE EAST BLOOD GLUCOSE MONITORING MARKET SIZE, BY SELF MONITORING DEVICES, 2018-2032 (USD MILLION)
TABLE 102. MIDDLE EAST BLOOD GLUCOSE MONITORING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 103. MIDDLE EAST BLOOD GLUCOSE MONITORING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 104. MIDDLE EAST BLOOD GLUCOSE MONITORING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 105. AFRICA BLOOD GLUCOSE MONITORING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 106. AFRICA BLOOD GLUCOSE MONITORING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 107. AFRICA BLOOD GLUCOSE MONITORING MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING SYSTEMS, 2018-2032 (USD MILLION)
TABLE 108. AFRICA BLOOD GLUCOSE MONITORING MARKET SIZE, BY SELF MONITORING DEVICES, 2018-2032 (USD MILLION)
TABLE 109. AFRICA BLOOD GLUCOSE MONITORING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 110. AFRICA BLOOD GLUCOSE MONITORING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 111. AFRICA BLOOD GLUCOSE MONITORING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 112. ASIA-PACIFIC BLOOD GLUCOSE MONITORING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 113. ASIA-PACIFIC BLOOD GLUCOSE MONITORING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 114. ASIA-PACIFIC BLOOD GLUCOSE MONITORING MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING SYSTEMS, 2018-2032 (USD MILLION)
TABLE 115. ASIA-PACIFIC BLOOD GLUCOSE MONITORING MARKET SIZE, BY SELF MONITORING DEVICES, 2018-2032 (USD MILLION)
TABLE 116. ASIA-PACIFIC BLOOD GLUCOSE MONITORING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 117. ASIA-PACIFIC BLOOD GLUCOSE MONITORING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 118. ASIA-PACIFIC BLOOD GLUCOSE MONITORING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 119. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 120. ASEAN BLOOD GLUCOSE MONITORING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 121. ASEAN BLOOD GLUCOSE MONITORING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 122. ASEAN BLOOD GLUCOSE MONITORING MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING SYSTEMS, 2018-2032 (USD MILLION)
TABLE 123. ASEAN BLOOD GLUCOSE MONITORING MARKET SIZE, BY SELF MONITORING DEVICES, 2018-2032 (USD MILLION)
TABLE 124. ASEAN BLOOD GLUCOSE MONITORING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 125. ASEAN BLOOD GLUCOSE MONITORING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 126. ASEAN BLOOD GLUCOSE MONITORING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 127. GCC BLOOD GLUCOSE MONITORING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 128. GCC BLOOD GLUCOSE MONITORING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 129. GCC BLOOD GLUCOSE MONITORING MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING SYSTEMS, 2018-2032 (USD MILLION)
TABLE 130. GCC BLOOD GLUCOSE MONITORING MARKET SIZE, BY SELF MONITORING DEVICES, 2018-2032 (USD MILLION)
TABLE 131. GCC BLOOD GLUCOSE MONITORING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 132. GCC BLOOD GLUCOSE MONITORING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 133. GCC BLOOD GLUCOSE MONITORING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 134. EUROPEAN UNION BLOOD GLUCOSE MONITORING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 135. EUROPEAN UNION BLOOD GLUCOSE MONITORING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 136. EUROPEAN UNION BLOOD GLUCOSE MONITORING MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING SYSTEMS, 2018-2032 (USD MILLION)
TABLE 137. EUROPEAN UNION BLOOD GLUCOSE MONITORING MARKET SIZE, BY SELF MONITORING DEVICES, 2018-2032 (USD MILLION)
TABLE 138. EUROPEAN UNION BLOOD GLUCOSE MONITORING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 139. EUROPEAN UNION BLOOD GLUCOSE MONITORING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 140. EUROPEAN UNION BLOOD GLUCOSE MONITORING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 141. BRICS BLOOD GLUCOSE MONITORING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 142. BRICS BLOOD GLUCOSE MONITORING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 143. BRICS BLOOD GLUCOSE MONITORING MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING SYSTEMS, 2018-2032 (USD MILLION)
TABLE 144. BRICS BLOOD GLUCOSE MONITORING MARKET SIZE, BY SELF MONITORING DEVICES, 2018-2032 (USD MILLION)
TABLE 145. BRICS BLOOD GLUCOSE MONITORING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 146. BRICS BLOOD GLUCOSE MONITORING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 147. BRICS BLOOD GLUCOSE MONITORING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 148. G7 BLOOD GLUCOSE MONITORING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 149. G7 BLOOD GLUCOSE MONITORING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 150. G7 BLOOD GLUCOSE MONITORING MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING SYSTEMS, 2018-2032 (USD MILLION)
TABLE 151. G7 BLOOD GLUCOSE MONITORING MARKET SIZE, BY SELF MONITORING DEVICES, 2018-2032 (USD MILLION)
TABLE 152. G7 BLOOD GLUCOSE MONITORING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 153. G7 BLOOD GLUCOSE MONITORING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 154. G7 BLOOD GLUCOSE MONITORING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 155. NATO BLOOD GLUCOSE MONITORING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 156. NATO BLOOD GLUCOSE MONITORING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 157. NATO BLOOD GLUCOSE MONITORING MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING SYSTEMS, 2018-2032 (USD MILLION)
TABLE 158. NATO BLOOD GLUCOSE MONITORING MARKET SIZE, BY SELF MONITORING DEVICES, 2018-2032 (USD MILLION)
TABLE 159. NATO BLOOD GLUCOSE MONITORING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 160. NATO BLOOD GLUCOSE MONITORING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 161. NATO BLOOD GLUCOSE MONITORING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 162. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 163. UNITED STATES BLOOD GLUCOSE MONITORING MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 164. UNITED STATES BLOOD GLUCOSE MONITORING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 165. UNITED STATES BLOOD GLUCOSE MONITORING MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING SYSTEMS, 2018-2032 (USD MILLION)
TABLE 166. UNITED STATES BLOOD GLUCOSE MONITORING MARKET SIZE, BY SELF MONITORING DEVICES, 2018-2032 (USD MILLION)
TABLE 167. UNITED STATES BLOOD GLUCOSE MONITORING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 168. UNITED STATES BLOOD GLUCOSE MONITORING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 169. UNITED STATES BLOOD GLUCOSE MONITORING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 170. CHINA BLOOD GLUCOSE MONITORING MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 171. CHINA BLOOD GLUCOSE MONITORING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 172. CHINA BLOOD GLUCOSE MONITORING MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING SYSTEMS, 2018-2032 (USD MILLION)
TABLE 173. CHINA BLOOD GLUCOSE MONITORING MARKET SIZE, BY SELF MONITORING DEVICES, 2018-2032 (USD MILLION)
TABLE 174. CHINA BLOOD GLUCOSE MONITORING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 175. CHINA BLOOD GLUCOSE MONITORING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 176. CHINA BLOOD GLUCOSE MONITORING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)

Companies Mentioned

The key companies profiled in this Blood Glucose Monitoring market report include:
  • Abbott Laboratories
  • AdvaCare Pharma
  • Advin Health Care
  • ARKRAY, Inc.
  • Ascensia Diabetes Care Holdings AG by PHC Holdings Corporation
  • B. Braun Melsungen AG
  • BAYER AG
  • Becton, Dickinson and Company
  • Dexcom, Inc.
  • F. Hoffmann-La Roche Ltd.
  • GlySens Incorporated
  • I-SENS, Inc.
  • Insulet Corporation
  • Johnson & Johnson Services, Inc.
  • LifeScan IP Holding, LLC.
  • Medtronic PLC
  • Medtrum Technologies Inc.
  • Nemaura Medical Inc.
  • Nipro Europe Group Companies
  • Nova Biomedical
  • Novo Nordisk A/s
  • NXP Semiconductors N.V.
  • PHC Holding Corporation
  • Prodigy Diabetes Care LLC
  • Sanofi S.A.
  • Senseonics Holdings Inc.
  • Sinocare Inc.
  • Teladoc Health, Inc.
  • Terumo Corporation
  • Ypsomed AG

Table Information

Report AttributeDetails
No. of Pages195
PublishedJanuary 2026
Forecast Period2026 - 2032
Estimated Market Value ( USD ) in 2026 $ 16.56 Billion
Forecasted Market Value ( USD ) by 2032 $ 27.23 Billion
Compound Annual Growth Rate8.6%
Regions CoveredGlobal
No. of Companies Mentioned31

Related Topics

Related Reports

Blood Glucose Monitor Market by Product Type (Self Blood Glucose Monitoring, Professional Point of Care), Application (Diabetes Management, Health & Wellness Monitoring), Test Site (Fingertip, Upper Arm), End User (Self/Homecare) - Global Forecast to 2030 - Product Image

Blood Glucose Monitor Market by Product Type (Self Blood Glucose Monitoring, Professional Point of Care), Application (Diabetes Management, Health & Wellness Monitoring), Test Site (Fingertip, Upper Arm), End User (Self/Homecare) - Global Forecast to 2030

  • Report
  • 302 Pages
  • Global
From
Global Blood Glucose Monitoring - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2025 - 2030) - Product Image

Global Blood Glucose Monitoring - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2025 - 2030)

  • Report
  • 236 Pages
  • Global
From
Blood Glucose Monitoring (BGM) Devices - A Global Market Overview - Product Image

Blood Glucose Monitoring (BGM) Devices - A Global Market Overview

  • Report
  • 246 Pages
  • Global
From
Diabetes Care Devices Market by Product Type (Blood Glucose Monitoring (CGM), Insulin Delivery Devices (Insulin Pumps (Tethered), Insulin Pens, Pen Needles), Application) Disease Type (Type 1, Type 2), End User (Homecare/Self) - Global Forecast to 2030 - Product Image

Diabetes Care Devices Market by Product Type (Blood Glucose Monitoring (CGM), Insulin Delivery Devices (Insulin Pumps (Tethered), Insulin Pens, Pen Needles), Application) Disease Type (Type 1, Type 2), End User (Homecare/Self) - Global Forecast to 2030

  • Report
  • 304 Pages
  • Global
From
Continuous Blood Glucose Monitoring Systems Market - Global Forecast 2026-2032 - Product Image

Continuous Blood Glucose Monitoring Systems Market - Global Forecast 2026-2032

  • Report
  • 195 Pages
  • Global
From

About the Market

The Blood Glucose Monitoring market is a subset of the Glucose Testing market, which is used to measure the amount of glucose in the blood. Blood Glucose Monitoring is used to diagnose and monitor diabetes, as well as to assess the effectiveness of diabetes treatments. It is also used to monitor glucose levels in people with other medical conditions, such as kidney disease. Blood Glucose Monitoring is typically done using a glucometer, which is a device that measures the amount of glucose in a sample of blood. The glucometer is usually used in conjunction with a test strip, which is a disposable strip that is used to collect a sample of blood. Some companies in the Blood Glucose Monitoring market include Abbott Laboratories, Roche Diagnostics, LifeScan, and Ascensia Diabetes Care. Show Less Read more

Copyright © 2002-2026 Research and Markets. All Rights Reserved.